BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,150.00
-20.00 (-0.39%)
Last updated: Apr 29, 2026, 2:16 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 522.33 billion as of April 28, 2026. Its market cap has increased by 10.11% in one year.
Market Cap
522.33B
Enterprise Value
186.17B
Revenue
118.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,150.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 522.33B, a decrease of -51.86%. That is a compound annual growth rate of -19.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 522.33B | -5.79% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| T&L Co., Ltd. | 508.29B |
| Value Added Technology | 345.36B |
| Vieworks | 238.17B |
| Dongbang Medical | 150.31B |
| Shinhung | 129.84B |
| CLASSYS | 3,875.00B |
| EOFLOW | 51.11B |
| PCL, Inc. | 17.87B |